JCRB0079 LU65
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
Profile | Human cell line with giant cell carcinoma of lung. | Other Name | LU65 |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 64 |
Identity | available | Tissue for Primary Cancer | lung (cancer) |
Case history | lung giant cell carcinoma | Metastasis | |
Tissue Metastasized | Genetics | c-Ki-ras2 mut. codon 12. ({3601,3602}) | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | many floating cells are observed |
Classify | tumor | Established by | Hirohashi,S. & Simosato,Y. |
Registered by | Suzuki,K. | Regulation for Distribution | |
Comment | Year | 1986 | |
Medium | RPMI1640 medium with 10% fetal calf serum. | Methods for Passages | Cells are treated with 0.02 % EDTA and 0.25 % trypsin. |
Cell Number on Passage | split ratio=1/10 | Race | Japanese |
CO2 Conc. | 5 % | Tissue Sampling | lung |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2197591 | Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y,Orita M,Shiraishi M,Hayashi K,Sekiya T Oncogene. 1990 Jul;5(7):1037-43 |
Pubmed id:2659722 | Purification and partial primary sequence of a chemotactic protein for polymorphonuclear leukocytes derived from human lung giant cell carcinoma LU65C cells. Suzuki K,Miyasaka H,Ota H,Yamakawa Y,Tagawa M,Kuramoto A,Mizuno S J Exp Med. 1989 Jun 1;169(6):1895-901 |
Pubmed id:3778442 | Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation. Yamada H,Yoshida T,Sakamoto H,Terada M,Sugimura T Biochem Biophys Res Commun. 1986 Oct 15;140(1):167-73 |
Pubmed id:3935627 | Giant cell carcinomas of the lung producing colony-stimulating factor in vitro and in vivo. Yamada T,Hirohashi S,Shimosato Y,Kodama T,Hayashi S,Ogura T,Gamou S,Shimizu N Jpn J Cancer Res. 1985 Oct;76(10):967-76 |
Pubmed id:6098458 | A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. Taya Y,Hosogai K,Hirohashi S,Shimosato Y,Tsuchiya R,Tsuchida N,Fushimi M,Sekiya T,Nishimura S EMBO J. 1984 Dec 1;3(12):2943-6 |
Images |
---|
LOT Information
Cell No. | JCRB0079 | Cell Name | |
---|---|---|---|
LOT No. | 12162008 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (GIBCO Cat. # 10099, lot 484375) | Temperature | 37 C |
Cell Density at Seeding | 1.3 - 4.7 x 10^5 cells/ml | Methods for Passages | Most cells are in suspension. Passage floating cells as well as attached cells by pipetting and dilution. |
Doubling Time | 35 - 40 hrs | Cell Number in Vial (cells/1ml) | 93.5 x 10^6 |
Viability at cell freezing (%) | 91.4 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 101093 | Lot Specification | distribution |
Medium | RPMI-1640 medium with 10% heat inactivated fetal bovine serum (JRS.DO10400) | Temperature | 37 C |
Cell Density at Seeding | 1.5x10^5 cells/ml | Methods for Passages | Cells are simply diluted to the fresh medium. |
Doubling Time | 21.7 hrs | Cell Number in Vial (cells/1ml) | 1.88x10^6 |
Viability at cell freezing (%) | 86.2 | Antibiotics Used | free |
Passage Number | P6* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD, LDH, NP |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Culture medium with 5% DMSO. | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 052791 | Lot Specification | distribution |
Medium | RPMI1640 + FCS 10% | Temperature | 37 C |
Cell Density at Seeding | dilution 1/10 | Methods for Passages | 0.02% EDTA and 0.05% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.1x10^6 |
Viability at cell freezing (%) | NT | Antibiotics Used | free |
Passage Number | P4* | PDL | |
Sterility: MYCOPLASMA | NT | Sterility: BACTERIA | NT |
Sterility: FUNGI | NT | Isozyme Analysis | NT |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 070489 | Lot Specification | distribution |
Medium | RPMI1640 + FCS 10% | Temperature | 37 |
Cell Density at Seeding | dilution 1/10 | Methods for Passages | 0.02% EDTA and 0.05% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.9x10^6 |
Viability at cell freezing (%) | 97% | Antibiotics Used | free |
Passage Number | P5* | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | NT |
Sterility: FUNGI | NT | Isozyme Analysis | NT |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 041486 | Lot Specification | distribution |
Medium | RPMI1640 + FCS 10% | Temperature | 37 |
Cell Density at Seeding | dilution 1/10 | Methods for Passages | 0.02% EDTA and 0.05% trypsin. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 0.9x10^6 |
Viability at cell freezing (%) | NT | Antibiotics Used | free |
Passage Number | P4* | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | AST,G6PD,LD,MD,MPI,NP,PEPB |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 01192016 | Lot Specification | distribution |
Medium | RPMI-1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091). | Temperature | 37 C |
Cell Density at Seeding | 2.1 - 3.0 x 10^5 cells/mL | Methods for Passages | Most of cells was round morphology and could be detached by pipetting, but some cells firmly attached to dishes and were treated with 0.1% trypsin. |
Doubling Time | approx. 46 hrs. | Cell Number in Vial (cells/1ml) | 2.2 x 10^6 |
Viability at cell freezing (%) | 89 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Y | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 89 | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 01192022 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Biowest Cat. # S1820-500) | Temperature | 37 C |
Cell Density at Seeding | 1.5 x 10^5 cells/mL | Methods for Passages | Most of cells was round morphology and could be detached by pipetting, but some cells firmly attached to dishes and were treated with 0.05% trypsin. |
Doubling Time | approx. 27 hrs. | Cell Number in Vial (cells/1ml) | 3.7 x 10^6 |
Viability at cell freezing (%) | 97 | Antibiotics Used | free |
Passage Number | Unknown (5 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Y/N | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 94 | Additional information |
Cell No. | JCRB0079 | Cell Name | LU65 |
---|---|---|---|
LOT No. | 03142024 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Nichirei Cat. # 174112, Lot 20M00K) | Temperature | 37C |
Cell Density at Seeding | 1.0 - 3.2 x 10^5 cells/mL | Methods for Passages | Most of cells was round morphology and could be detached by pipetting, but some cells firmly attached to dishes and were treated with 0.05% trypsin. |
Doubling Time | approx. 27 hrs. | Cell Number in Vial (cells/1ml) | 3.5 x 10^6 |
Viability at cell freezing (%) | 95 | Antibiotics Used | free |
Passage Number | Unknown (5 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Y/N | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 93 | Additional information |